Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis

Tyrosine kinase inhibitor therapy revolutionized chronic myeloid leukemia treatment and showed how targeted therapy and molecular monitoring could be used to substantially improve survival outcomes. We used chronic myeloid leukemia as a model to understand a critical question: why do some patients h...

Descripción completa

Detalles Bibliográficos
Autores principales: Radich, Jerald P., Wall, Matthew, Branford, Susan, Campbell, Catarina D., Chaturvedi, Shalini, DeAngelo, Daniel J., Deininger, Michael W., Guinney, Justin, Hochhaus, Andreas, Hughes, Timothy P., Kantarjian, Hagop M., Larson, Richard A., Li, Sai, Maegawa, Rodrigo, Mishra, Kaushal, Obourn, Vanessa, Pinilla-Ibarz, Javier, Purkayastha, Das, Sadek, Islam, Saglio, Giuseppe, Shrestha, Alok, White, Brian S., Druker, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Article - Chronic Myeloid Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230428/
https://www.ncbi.nlm.nih.gov/pubmed/36727397
http://dx.doi.org/10.3324/haematol.2022.281878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230428/
https://www.ncbi.nlm.nih.gov/pubmed/36727397
http://dx.doi.org/10.3324/haematol.2022.281878

Ejemplares similares